Ternary Therapeutics
TernaryTx, a pioneering biotech startup, with a revolutionary AI-driven platform for designing molecular glue therapeutics, opening new frontiers in drug discovery for previously "undruggable" targets.
London, UKwww.ternarytx.co.uk ↗
Total raised
€4.2M
€4,166,435
Funding rounds
1
Investors
4
distinct backers
Active since
2026-03
latest 2026-03
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood28
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-18 | Seed | €4.2M | Future Planet Capital,i&i Biotech Fund,Pace Ventures,The UK Innovation & Science Seed Fund | View deal → |